Pharmafile Logo
Pharmafocus logo
Advanced Search
Belén Garijo image

Merck makes big changes at the top

October 1, 2013
Medical Communications, Sales and Marketing Merck, Merck Serono

Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …

News
gsk image

Aspen buys GSK plant and thrombosis drugs for $1.1 billion

October 1, 2013
Manufacturing and Production, Sales and Marketing GSK, aspen

South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …

News

Cancer survival rates linked to government spending in EU

October 1, 2013
Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

News
boehringer image

Boehringer cancer drug impresses

October 1, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …

News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013
Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

News
oliver_brandicourt_bayer

Oliver Brandicourt joins Bayer from Pfizer

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …

Appointment

Sanofi starts work on ‘largest African facility’

September 30, 2013
Manufacturing and Production, Sales and Marketing Africa, Sanofi, algeria

Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …

News
Roche image

Roche cancer treatment shows promise

September 30, 2013
Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche

An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …

News
GSK image

GSK in Barclays deal

September 30, 2013
Sales and Marketing GSK, Zambia, barclays, csr

GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …

News
hunt image

Cancer Drugs Fund to run until 2016

September 30, 2013
Research and Development, Sales and Marketing CDF, Cameron, NHS, NICE, VBP

England’s Cancer Drugs Fund will run until 2016 and be given a £400 million boost under plans announced by the …

News
dan_feldman_president_inventiv_health_europe

InVentiv Health makes strategic appointments

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health

Healthcare consultancy firm InVentiv Health has created two new positions
 to lead its growing business opportunities in Europe and Asia. …

Appointment
EMA building

The future of data disclosure in Europe

September 30, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency

The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …

Feature

Boehringer cuts ribbon on €70m addition to Shanghai plant

September 27, 2013
Manufacturing and Production, Sales and Marketing Boehringer, China, Shanghai

Boehringer Ingelheim has officially opened the €70 million expansion of its facility in Zhangjiang, China, that is designed to triple …

News
NICE

NICE recommends ovarian cancer drug Caelyx

September 27, 2013
Sales and Marketing NICE, Yondelis, ovarian cancer

News
NHS image

Cancer Drugs Fund to stay, government to announce

September 27, 2013
Medical Communications, Sales and Marketing CDF, Cameron, NHS, NICE, VBP, prime minister

The UK’s prime minister is set to announce that the controversial Cancer Drugs Fund will remain in place after March …

News
Dara Ó Briain image

PM Society’s digital award winners announced

September 27, 2013
Medical Communications, Sales and Marketing digital awards, pm society

 The independent comms agency Ruder Finn and creative marketing shop Digitas Healthcare won most recognition at the PM Society Digital …

News
Diovan image

Novartis ‘sorry’ for Diovan data

September 27, 2013
Sales and Marketing Japan, Novartis, diovan data

Novartis has apologised to patients in Japan over the alleged manipulation of data in five trials of its blockbuster blood …

News
sophie_mcgrath_brown_rudnick

Brown Rudnick appoints partner

September 27, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brown rudnick

Sophie McGrath has joined law firm Brown Rudnick as a partner and is to focus on life sciences at the …

Appointment
Bayer image

Bayer slammed for ‘nightcaps’

September 26, 2013
Medical Communications, Sales and Marketing ABPI, Bayer, PMCPA

Bayer has come under fire from the PMCPA for providing late-night drinks to delegates at a conference in Amsterdam, exceeding …

News
amgen image

Amgen to open Chinese R&D centre

September 26, 2013
Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang

Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026